Back

Tumoral CD24 tunes platelets binding and pro-metastatic functions

Mittelheisser, V.; Liboni, C.; Mouriaux, C.; Trivigno, S. M. G.; Bochler, L.; Garcia-Leon, M.; Larnicol, A.; Paulen, L.; Stemmelen, T.; Mangin, P. H.; Lefebvre, O.; GOETZ, J. G.

2025-04-15 cancer biology Community evaluation
10.1101/2025.04.09.648049 bioRxiv
Show abstract

One of the earliest steps of breast cancer metastasis occurs when tumor cells (TCs) disseminate through the bloodstream. There, they interact with several blood components. Among them, platelet favor TC survival and metastatic spread. While the binding of platelet to TC is highly variable, its molecular controls and downstream consequences remain unidentified. Here, we first document that high CD24 expression correlates with increased platelet binding and poorer survival in breast cancer. We further demonstrate that CD24-mediated platelet binding regulates TC cluster formation and resistance to anoikis in vitro. Depleting CD24 expression significantly reduces TC metastatic potential by rewiring the metastatic tumor microenvironment (mTME), affecting immune compartments and secreted factors. Overall, our work identifies CD24 as a molecular cue controlling TC-platelet interaction, dictating their metastatic potential. As such, it represents a druggable target to counteract platelet-TC collaboration in metastasis.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.